.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
McKinsey
Merck
QuintilesIMS
Fuji
Julphar
Cipla
McKesson
UBS
Express Scripts

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074305

« Back to Dashboard
NDA 074305 describes GLIPIZIDE, which is a drug marketed by Sandoz, Barr Labs Inc, Unique Pharm Labs, Sun Pharm Inds Inc, Watson Labs Teva, Mylan, Aurobindo Pharma Ltd, Accord Hlthcare, Par Pharm, Watson Labs, Vintage Pharms Llc, Ani Pharms Inc, Apotex, Mylan Pharms Inc, Zydus Pharms Usa Inc, Epic Pharma Llc, Heritage Pharms Inc, and Teva Pharms, and is included in twenty-four NDAs. It is available from fifty-three suppliers. Additional details are available on the GLIPIZIDE profile page.

The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.

Summary for NDA: 074305

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 074305

Ingredient-typeSulfonylurea Compounds

Suppliers and Packaging for NDA: 074305

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLIPIZIDE
glipizide
TABLET;ORAL 074305 ANDA Sandoz Inc 0781-1452 0781-1452-01 100 TABLET in 1 BOTTLE (0781-1452-01)
GLIPIZIDE
glipizide
TABLET;ORAL 074305 ANDA Sandoz Inc 0781-1452 0781-1452-10 1000 TABLET in 1 BOTTLE (0781-1452-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Apr 7, 1995TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Apr 7, 1995TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Mallinckrodt
Farmers Insurance
Daiichi Sankyo
Argus Health
Queensland Health
Chubb
Novartis
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot